Delivery Order SPE2DB24D2100-SPE2DB25FBFHH
- Not listed
- This is a $13,618.40 delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The firm-fixed-price contract runs through July 25, 2024 and was awarded on a full and open competition basis without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company,...
- This contract award, valued at $34,017.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical medication used in the treatment of COVID-19. The contract has a completion date of October 7, 2021 and utilizes a Firm Fixed Price pricing structure. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The contract is a firm fixed-price Delivery Order with a ceiling value of $4,754.64 and an ultimate completion date of February 13, 2025. The contract is not set aside for any specific business category....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a medication used to treat COVID-19. The contract has a firm fixed price of $9,113.06 and a performance period extending through May 28, 2025. This contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,809.20 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a medication used to treat COVID-19. The contract has an ultimate completion date of August 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $13,618.40 contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a COVID-19 treatment medication. The contract has a completion date of February 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,401.70 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a critical medication used in the treatment of COVID-19. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Veklury (Remdesivir) 100 mg vials. The $8,851.96 firm-fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The $13,606.80 firm-fixed-price contract has an ultimate completion date of March 1, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,754.64, is for the delivery of the drug VEKLURY (Remdesivir) 100 mg vials. It is a firm fixed-price contract with a completion date of June 2, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFHHDelivery Order
This federal contract award, valued at $3,962.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of August 7, 2025. It is not a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and running through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 7/17/25 |